Ajanta Pharma Limited

NSE AJANTPHARM.NS

Ajanta Pharma Limited Revenue for the year ending March 31, 2024: USD 504.58 M

Ajanta Pharma Limited Revenue is USD 504.58 M for the year ending March 31, 2024, a 10.81% change year over year. Revenue is the total amount of money generated from the sales of goods or services by a company during a specific period.
  • Ajanta Pharma Limited Revenue for the year ending March 31, 2023 was USD 455.37 M, a 5.28% change year over year.
  • Ajanta Pharma Limited Revenue for the year ending March 31, 2022 was USD 432.52 M, a 11.24% change year over year.
  • Ajanta Pharma Limited Revenue for the year ending March 31, 2021 was USD 388.82 M, a 14.37% change year over year.
  • Ajanta Pharma Limited Revenue for the year ending March 31, 2020 was USD 339.95 M, a 17.16% change year over year.
Key data
Date Revenue Gross Profit Operating Income EBIT
Market news
Loading...
NSE: AJANTPHARM.NS

Ajanta Pharma Limited

CEO Mr. Yogesh Mannalal Agrawal M.B.A
IPO Date July 1, 2002
Location India
Headquarters Ajanta House
Employees 8,073
Sector Health Care
Industries
Description

Ajanta Pharma Limited, a specialty pharmaceutical formulation company, together with its subsidiaries, develops, manufactures, and markets finished dosages. The company markets and serves various therapeutic segments, such as anti-biotic, anti-malarial, anti-diabetic, cardiology, gynecology, pediatric, respiratory and general health products, dermatology, ophthalmology, and pain management areas. It also provides multivitamins, antibiotics, eye drops, cough syrups, etc. The company serves in India, Africa, rest of Asia, the United States, and internationally. It supplies its products to government bodies, including armed forces, government hospitals, canteens, stores department, etc. The company was founded in 1973 and is headquartered in Mumbai, India.

Similar companies

IPCALAB.NS

Ipca Laboratories Limited

USD 18.35

0.69%

TORNTPHARM.NS

Torrent Pharmaceuticals Limited

USD 37.58

0.68%

APLLTD.NS

Alembic Pharmaceuticals Limited

USD 11.66

0.86%

ALKEM.NS

Alkem Laboratories Limited

USD 60.83

0.86%

NATCOPHARM.NS

NATCO Pharma Limited

USD 14.52

3.84%

StockViz Staff

January 15, 2025

Any question? Send us an email